These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 8799682)

  • 1. New antiherpesvirus agents. Their targets and therapeutic potential.
    Alrabiah FA; Sacks SL
    Drugs; 1996 Jul; 52(1):17-32. PubMed ID: 8799682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in herpesvirus therapy.
    Naesens L; De Clercq E
    Herpes; 2001 Mar; 8(1):12-6. PubMed ID: 11867011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis against herpesvirus infections in transplant recipients.
    Ljungman P
    Drugs; 2001; 61(2):187-96. PubMed ID: 11270937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral prophylaxis in organ transplant patients.
    Slifkin M; Doron S; Snydman DR
    Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
    Wagstaff AJ; Faulds D; Goa KL
    Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
    Wutzler P
    Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
    Tan HH; Goh CL
    Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
    Reusser P
    J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral skin infections in the elderly: diagnosis and management.
    Bansal R; Tutrone WD; Weinberg JM
    Drugs Aging; 2002; 19(7):503-14. PubMed ID: 12182687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.
    Snoeck R; Andrei G; De Clercq E
    Drugs; 1999 Feb; 57(2):187-206. PubMed ID: 10188760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.
    El-Haddad D; El Chaer F; Vanichanan J; Shah DP; Ariza-Heredia EJ; Mulanovich VE; Gulbis AM; Shpall EJ; Chemaly RF
    Antiviral Res; 2016 Oct; 134():58-62. PubMed ID: 27582067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients.
    Fillet AM
    Drugs Aging; 2002; 19(5):343-54. PubMed ID: 12093321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antivirals for the treatment of herpesvirus infections.
    De Clercq E
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():121-32. PubMed ID: 8407694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.
    De Clercq E; Naesens L; De Bolle L; Schols D; Zhang Y; Neyts J
    Rev Med Virol; 2001; 11(6):381-95. PubMed ID: 11747000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Wagstaff AJ
    Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic antivirals in herpesvirus infections.
    Sasadeusz JJ; Sacks SL
    Dermatol Clin; 1993 Jan; 11(1):171-85. PubMed ID: 8382122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent clinical experience with famciclovir--a "third generation" nucleoside prodrug.
    Chakrabarty A; Tyring SK; Beutner K; Rauser M
    Antivir Chem Chemother; 2004 Sep; 15(5):251-3. PubMed ID: 15535046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral drugs for varicella-zoster virus and herpes simplex virus infections.
    Med Lett Drugs Ther; 2018 Sep; 60(1556):153-157. PubMed ID: 30383727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.